Ascletis Pharma Inc. announces completion of enrollment in its 13-week U.S. Phase II study (NCT07321678) evaluating ASC30, an oral small molecule GLP-1 receptor (GLP-1R) agonist, for the treatment of type 2 diabetes mellitus (T2D). T2D is the...
entitled, "WORMS-Defined Meniscal Pathology is Associated with Femoral Bone-Shape Change, with Attenuation in IA TPX-100 Treated Knees" (Poster #665) at the Osteoarthritis Research Society International (OARSI) 2026 World Congress in West Palm...
and Alzheimer's disease. The tools to visualize them with molecular precision have not existed until now. Over the next 12 months, he plans to validate working prototypes and assemble a team to scale them into essential laboratory tools....
the legs (deep vein thrombosis [DVT]) or lungs (pulmonary embolism [PE]), and reduce the risk of them recurring. For every 100,000 patients treated, Eliquis has resulted in an estimated $3 billion in total healthcare cost savings and avoidance,...
option that advances the standard of care for people living with this complex condition." At Month 24 of the study, 69% (103/149) of participants achieved a physiologic GC dose (≤11 mg/m2/day hydrocortisone equivalents), with many participants...
announced that the U.S. Food and Drug Administration (FDA) approved IDVYNSO™, a new, two-drug single-tablet regimen of 100 mg doravirine and 0.25 mg islatravir, for the treatment of HIV-1 infection in adults to replace the current antiretroviral...
Orthogon Therapeutics announced the closing of a follow-on $11 million financing, bringing its total capital raised to $36 million. This financing supports the continued advancement of its first-in-class drug against BK polyomavirus. BK virus...
stage of the most important research, development and production activities at more than 300,000 customer locations in 180 countries. For more information, please visit www.avantorsciences.com
patient rotation during spine surgery is a time-intensive process that increases physical strain on operating room staff.1 Designed to support safe, quick and easy patient maneuvering during spine surgery, the AAT XR allows surgical teams to rotate...
company, announced eligible patients can now access Foundayo™ (orforglipron) – Eli Lilly Company's newest oral GLP-1 innovation – on the Ro platform, adding to Ro's already comprehensive formulary of FDA-approved GLP-1s. Foundayo™ is a once daily...
from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Nintedanib Capsules, 100 mg and 150 mg, the generic equivalent of OFEV® (nintedanib) capsules1. Nintedanib is indicated for the treatment of...
BD a leading global medical technology company, announced the launch of the HemoSphere Stream™ Module, a new innovation which gives clinicians continuous, noninvasive visibility into patients' blood pressure. The module delivers real-time,...
and transplant hepatology by the American Board of Internal Medicine and joined the UT Southwestern faculty in 2010. His research focuses on monitoring liver cirrhosis patients, in particular for diagnosing and treating liver cancer before it...
hubs for global beauty consumers. In addition, MEDIPEEL has entered Namsi Pharmacy, a heritage pharmacy established in 1954 and operated across three generations, further strengthening its presence within Korea's trusted K-Pharmacy network. The...
with neurological conditions. The company advances work originally developed by iota Biosciences, which was founded in 2017 to pioneer cutting‑edge bioelectronic technologies and is now powered by Astellas. Epia Neuro’s platform integrates...
molecular preorganization, thereby accelerating covalent bond formation without increasing intrinsic reactivity (Fig. 1). Based on this concept, the team developed a high-throughput platform that combines yeast surface display with chemoselective...
13th International Conference on Chemical and Biological Sciences (ICCBS 2026) will be held in Osaka, Japan during, co-sponsored by Network Joint Research Center for Materials and Devices: Dynamic Alliance for Open Innovation Bridging Human,...
Tiger BioSciences announced the launch of carePAC™, a line of pre-configured wound care convenience kits designed to simplify dressing changes and improve access to essential wound care supplies for patients managing wounds at home. carePAC™ kits...
fed-batch cultures, establishing stable pools in as little as four weeks, and supporting selection of stable clones within 14 weeks, helping to streamline progression from early development to commercial manufacturing. “Biologics developers face...
Orca Bio, a late-stage biotechnology company committed to transforming the lives of patients through high-precision cell therapy, announced that the U.S. Food and Drug Administration (FDA) has extended the review timeline of its Biologics License...